Anastasiia Rohozianska

Novo Nordisk has entered a strategic partnership with OpenAI to integrate AI systems across its research, manufacturing, and commercial workflows. Initial pilot programs are expected across R&D, manufacturing, and commercial units, with broader rollout planned through 2026.

Boston-based Life Biosciences, co-founded by David Sinclair, has closed an $80 million Series D financing to fund its first-in-human clinical program and extend operations into 2027. The capital is allocated primarily to a Phase 1 trial of ER-100 …

Jeito Capital has closed its second fund, Jeito II, at more than €1 billion, or about $1.2 billion, giving the Paris-based investor a larger pool of capital for clinical-stage biopharma companies in Europe. The firm says the close …

Anthropic is reported to have acquired Coefficient Bio, a recently founded AI-driven biotech startup with a team of less than ten people, in a transaction valued at approximately $400 million in stock. The deal centers on integrating a …

A San Francisco startup Epia Neuro launched today with a minimally invasive brain-computer interface (BCI) designed to help stroke survivors regain motor function by reading what the brain intends to do and translating that into actual movement.

Paris-based techbio Generare has raised €20 million in a Series A round co-led by Alven and daphni, with participation from existing investors. The company is focused on generating previously inaccessible small-molecule data by decoding microbial genomes, aiming to expand …

After reporting the first patient dosed in September 2025, early clinical data from a small open-label study indicate that Enveda’s oral candidate, discovered via the company’s PRISM AI platform, ENV-294, produced rapid reductions in disease severity and itch …

Insilico Medicine and Eli Lilly have entered a multi-program AI-driven drug discovery collaboration, combining Insilico’s generative modeling platforms with Lilly’s clinical and commercialization infrastructure. Under the agreement, Insilico receives $115 million upfront, with potential milestone payments bringing the total …

Meta has released TRIBE v2, an open-source foundation model designed to predict human brain responses to visual and auditory stimuli and construct a digital twin of neural activity. The model is trained on more than 500 hours …

Clockwork Bio has been launched as a new AI-native biotech focused on redesigning early-stage oncology drug discovery. The company is developing a platform centered on modeling and controlling cell state transitions, aiming to address limitations in current pipelines that …